|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim C, Kim WR, Kim KY, Chon HJ, Beom SH,
Kim H, Jung M, Shin SJ, Kim NK and Ahn JB: Predictive nomogram for
recurrence of stage I colorectal cancer after curative resection.
Clin Colorectal Cancer. 17:e513–e518. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Forrest ME and Khalil AM: Review:
Regulation of the cancer epigenome by long non-coding RNAs. Cancer
Lett. 407:106–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ni W, Yao S, Zhou Y, Liu Y, Huang P, Zhou
A, Liu J, Che L and Li J: Long noncoding RNA GAS5 inhibits
progression of colorectal cancer by interacting with and triggering
YAP phosphorylation and degradation and is negatively regulated by
the m6A reader YTHDF3. Mol Cancer. 18:1432019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang HQ, Meng YL, Lu QL, Dou YY, Liang LL
and Luo Y: Decreased long noncoding RNA ADIPOQ promoted cell
proliferation and metastasis via miR-219c-3p/TP53 pathway in
colorectal carcinoma. Eur Rev Med Pharmacol Sci. 24:7645–7654.
2020.PubMed/NCBI
|
|
9
|
Bian Z, Zhang J, Li M, Feng Y, Wang X,
Zhang J, Yao S, Jin G, Du J, Han W, et al: LncRNA-FEZF1-AS1
promotes tumor proliferation and metastasis in colorectal cancer by
regulating PKM2 signaling. Clin Cancer Res. 24:4808–4819. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang J, Yan T, Bao Y, Shen C, Yu C, Zhu X,
Tian X, Guo F, Liang Q, Liu Q, et al: LncRNA GLCC1 promotes
colorectal carcinogenesis and glucose metabolism by stabilizing
c-Myc. Nat Commun. 10:34992019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hua Q, Jin M, Mi B, Xu F, Li T, Zhao L,
Liu J and Huang G: LINC01123, a c-Myc-activated long non-coding
RNA, promotes proliferation and aerobic glycolysis of non-small
cell lung cancer through miR-199a-5p/c-Myc axis. J Hematol Oncol.
12:912019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pan X, Tan J, Tao T, Zhang X, Weng Y, Weng
X, Xu J, Li H, Jiang Y, Zhou D and Shen Y: LINC01123 enhances
osteosarcoma cell growth by activating the Hedgehog pathway via the
miR-516b-5p/Gli1 axis. Cancer Sci. 112:2260–2271. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang M, Han Y, Zheng Y, Zhang Y, Zhao X,
Gao Z and Liu X: ZEB1-activated LINC01123 accelerates the
malignancy in lung adenocarcinoma through NOTCH signaling pathway.
Cell Death Dis. 11:9812020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li JH, Liu S, Zheng LL, Wu J, Sun WJ, Wang
ZL, Zhou H, Qu LH and Yang JH: Discovery of protein-lncRNA
interactions by integrating large-scale CLIP-Seq and RNA-Seq
datasets. Front Bioeng Biotechnol. 2:882015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu X, Yan F, Wang L, Sun G, Liu J, Qu M,
Wang Y and Li T: MicroRNA: Another pharmacological avenue for
colorectal cancer? Front Cell Dev Biol. 8:8122020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang L, Zhang Y, Li Z, Zhao X, Xi Z, Chen
H, Shi H, Xin T, Shen R and Wang T: MiR-4319 suppresses colorectal
cancer progression by targeting ABTB1. United European
Gastroenterol J. 7:517–528. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Li N, Dong Y, Li S, Xu L, Li X, Li
Y, Li Z, Ng SS, Sung JJ, et al: miR-34a-5p suppresses colorectal
cancer metastasis and predicts recurrence in patients with stage
II/III colorectal cancer. Oncogene. 34:4142–4152. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li S, Zhu K, Liu L, Gu J, Niu H and Guo J:
lncARSR sponges miR-34a-5p to promote colorectal cancer invasion
and metastasis via hexokinase-1-mediated glycolysis. Cancer Sci.
111:3938–3952. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zeng C, Hu J, Pan Y, Shan Y, Liu B
and Jia L: Long non-coding RNA-SNHG7 acts as a target of miR-34a to
increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in
colorectal cancer progression. J Hematol Oncol. 11:892018.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rokavec M, Öner MG, Li H, Jackstadt R,
Jiang L, Lodygin D, Kaller M, Horst D, Ziegler PK, Schwitalla S, et
al: IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated
colorectal cancer invasion and metastasis. J Clin Invest.
124:1853–1867. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gatenby RA and Gillies RJ: Why do cancers
have high aerobic glycolysis? Nat Rev Cancer. 4:891–899. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji S, Zhang B, Liu J, Qin Y, Liang C, Shi
S, Jin K, Liang D, Xu W, Xu H, et al: ALDOA functions as an
oncogene in the highly metastatic pancreatic cancer. Cancer Lett.
374:127–135. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu H, Gao H, Qi X, Zhao L, Wu D, Bai Y, Li
H, Liu X, Hu J and Shao S: Aldolase A promotes proliferation and
G1/S transition via the EGFR/MAPK pathway in non-small
cell lung cancer. Cancer Commun (Lond). 38:182018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kukita A, Yoshida MC, Fukushige S,
Sakakibara M, Joh K, Mukai T and Hori K: Molecular gene mapping of
human aldolase A (ALDOA) gene to chromosome 16. Hum Genet.
76:20–26. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Zhang X, Jin Z, Yin T, Duan C, Sun
J, Xiong R and Li Z: MiR-122 promotes the development of colon
cancer by targeting ALDOA in vitro. Technol Cancer Res Treat.
18:15330338198713002019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai L, Pan G, Liu X, Huang J, Jiang Z, Zhu
X, Gan X, Xu Q and Tan N: High expression of ALDOA and DDX5 are
associated with poor prognosis in human colorectal cancer. Cancer
Manag Res. 10:1799–1806. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang XJ, Wang W and Hann SS: Interactions
among lncRNAs, miRNAs and mRNA in colorectal cancer. Biochimie.
163:58–72. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Heneghan HM, Miller N and Kerin MJ: MiRNAs
as biomarkers and therapeutic targets in cancer. Curr Opin
Pharmacol. 10:543–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun DE and Ye SY: Emerging roles of long
noncoding RNA regulator of reprogramming in cancer treatment.
Cancer Manag Res. 12:6103–6112. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin X, Zhuang S, Chen X, Du J, Zhong L,
Ding J, Wang L, Yi J, Hu G, Tang G, et al: lncRNA ITGB8-AS1
functions as a ceRNA to promote colorectal cancer growth and
migration through integrin-mediated focal adhesion signaling. Mol
Ther. 30:688–702. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang M, Weng W, Zhang Q, Wu Y, Ni S, Tan
C, Xu M, Sun H, Liu C, Wei P and Du X: The lncRNA NEAT1 activates
Wnt/β-catenin signaling and promotes colorectal cancer progression
via interacting with DDX5. J Hematol Oncol. 11:1132018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med
(Berl). 94:1313–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dragutinović VV, Radonjić NV, Petronijević
ND, Tatić SB, Dimitrijević IB, Radovanović NS and Krivokapić ZV:
Matrix metalloproteinase-2 (MMP-2) and −9 (MMP-9) in preoperative
serum as independent prognostic markers in patients with colorectal
cancer. Mol Cell Biochem. 355:173–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bao Y, Lu Y, Feng W, Yu H, Guo H, Tao Y,
Shi Q, Chen W and Wang X: COUP-TFII promotes epithelial-mesenchymal
transition by inhibiting miR-34a expression in colorectal cancer.
Int J Oncol. 54:1337–1344. 2019.PubMed/NCBI
|
|
37
|
Lunt SY and Vander Heiden MG: Aerobic
glycolysis: Meeting the metabolic requirements of cell
proliferation. Annu Rev Cell Dev Biol. 27:441–464. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Tochio T, Tanaka H, Nakata S and Hosoya H:
Fructose-1,6-bisphosphate aldolase A is involved in HaCaT cell
migration by inducing lamellipodia formation. J Dermatol Sci.
58:123–129. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kawai K, Uemura M, Munakata K, Takahashi
H, Haraguchi N, Nishimura J, Hata T, Matsuda C, Ikenaga M, Murata
K, et al: Fructose-bisphosphate aldolase A is a key regulator of
hypoxic adaptation in colorectal cancer cells and involved in
treatment resistance and poor prognosis. Int J Oncol. 50:525–534.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li X, Zhao S, Fu Y, Zhang P, Zhang Z,
Cheng J, Liu L and Jiang H: miR-34a-5p functions as a tumor
suppressor in head and neck squamous cell cancer progression by
targeting Flotillin-2. Int J Biol Sci. 17:4327–4339. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang X, Sun Q, Song Y and Li W: circHUWE1
exerts an oncogenic role in inducing DDP-resistant NSCLC
progression depending on the regulation of miR-34a-5p/TNFAIP8. Int
J Genomics. 2021:39970452021. View Article : Google Scholar : PubMed/NCBI
|
